Invesco
VRCA icon

Invesco’s Verrica Pharmaceuticals VRCA Stock Holding History

Invesco’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-7,439
Closed -$32.9K – 3884
2025
Q1 		$32.9K Buy
7,439
+2,926
+65% +$18.9K ﹤0.01% 3724
2024
Q4 		$31.6K Buy
+4,513
New +$49.6K ﹤0.01% 3723
2024
Q3 		– Sell
-42,352
Closed -$3.09M – 3897
2024
Q2 		$3.09M Buy
+42,352
New +$3.25M ﹤0.01% 2407
2023
Q4 		– Sell
-1,066
Closed -$41.4K – 3898
2023
Q3 		$41.4K Hold
1,066
– – ﹤0.01% 3814
2023
Q2 		$61.5K Buy
+1,066
New +$64.7K ﹤0.01% 3799

Other funds holding VRCA

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SA
Sovran Advisors San Diego, California $1.34B AUM 21.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Invesco's VRCA Position: Q2 2025 in Review

Invesco sold out of Verrica Pharmaceuticals (VRCA) in Q2 2025, closing a stake of 7,439 shares — an estimated $32.9K sold.

Invesco first reported a position in VRCA in Q2 2023 and held it in 5 quarters. The position peaked at $3.09M in Q2 2024. 58 funds tracked by Wall St. Rank hold VRCA as of Q2 2025.

  • Invesco reported no remaining Verrica Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Invesco sold 7,439 Verrica Pharmaceuticals shares in Q2 2025, an estimated $32.9K.
  • Invesco first reported a position in Verrica Pharmaceuticals in Q2 2023 and held it in 5 quarters.
  • Invesco's Verrica Pharmaceuticals position peaked at $3.09M in Q2 2024.
  • 58 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q2 2025.

Based on Invesco's 13F filing for Q2 2025, filed 13 Aug 2025.